[Skip to Content]
Upstate Medical University Logo
Accessibility Menu MENU

Peer-Reviewed Publications

2024

  • Amedeo V, Seabury RW, Meola G, Barbay E, Feldman EA. Effect of Etomidate on Systolic Blood Pressure in Emergency Department Patients Undergoing Rapid Sequence Intubation with High and Low Shock Index. Eur J Emerg Med. 2024 Aug 1;31(4):294-296. doi: 10.1097/MEJ.0000000000001144. Epub 2024 Jun 25.
  • Coli KG, Noviasky JA, Ulen KR, Guan J, McCall KL, Yuksel JM. Utilization of Lower-Dose Cyclobenzaprine in the Older Inpatient. Sr Care Pharm 2024 Jul 1;39(7):249-258. doi: 10.4140/TCP.n.2024.249. PMID: 38937891.
  • Yuksel JM, Noviasky JA, Ulen KR, Brenner JM, Brangman SA. Improved Outcomes When Home – Dose Carbidopa-Levodopa Is Continued in the Geriatric Emergency Department in Patients with Parkinson’s Disease. Sr Care Pharm 2024 Jul 1;39(7):242-248. doi: 10.4140/TCP.n.2024.242. PMID: 38937894.
  • Hitchcock AM, Kufel WD, Mastro KA, Sidman EF. Lenacapavir: A novel injectable HIV-1 capsid inhibitor. Int J Antimicrob Agents. 2024 Jan;63(1):107009. doi: 10.1016/j.ijantimicag.2023.107009. Epub 2023 Oct 14.

2023

  • Morley H, Seabury RW, Parsels KA, Miller CD, Darko W, Schrader J, Meola G. Preparation/administration of push-dose versus continuous infusion epinephrine and phenylephrine: A simulation. Am J Emerg Med. 2023 Dec:74:135-139. Doi: 10.1016/j.ajem.2023.10002. Epub 2023 Oct 2.
  • Geskey JM, Yuksel JM, Snead JA, Noviasky JA, Brummel G, Shippey E. Factors Associated with Acute Injurious Falls in Elderly Hospitalized Patients: A Multicenter Descriptive Study. Jt Comm J Qual Patient Saf. 2023 Nov;49(11):604-612. doi: 10.1016/j.jcjq.2023.06.016. Epub 2023 Jul 5. PMID: 37487930.
  • Yuksel JM, Ulen KR, Varghese D, Noviasky JA. Pharmacist Involvement in an Acute Care of the Elderly Team: Impact on Appropriate Medication Use. Sr Care Pharm. 2023 Aug 1;38(8):338-345. doi: 10.4140/TCP.n.2023.338. PMID: 37496166.

2022

  • Cheung NC, Noviasky JA, Ulen KR, Brangman SA. Efficacy and safety of megestrol in the hospitalized older person. Sr Care Pharm. 2022: 1;37(7):284-292
  • Morley CP, Schad LA, Cerio H, McNamara SE, Wojtowycz MA, Smith NH, Noviasky JA, Ulen KR, Townsend K, Amidon J, Brangman SA. Longitudinal Evaluation of a Deprescribing Protocol in Skilled Nursing Facilities. Sr Care Pharm. 2022 Oct 1;37(10):523-531. doi: 10.4140/TCP.n.2022.523. PMID: 36171671.
  • Field AM, Seabury RW, Kufel WD, Darko W, Miller CD, Mastro KA, Steele JM. Single-dose antibiotic prophylaxis with ertapenem increases compliance with recommendations for surgical antibiotic prophylaxis in elective colorectal surgery: A retrospective, single center analysis. Surgical Infections, 2022. Epub ahead of print.
  • Hitchcock AM, Seabury RW, Kufel WD, Farooqi S, Steele JM, Darko WD, Miller CD, Feldman EA. Does a positive methicillin-resistant Staphylococcus aureus (MRSA) nasal screen predict the risk for MRSA skin and soft tissue infection? Annals of Pharmacotherapy. 2022. Epub ahead of print.
  • Chen D, Seabury RW, Steele JM, Darko W, Miller CD, Kufel WD. Evaluation of B-lactam therapeutic drug monitoring among UH health systems with postgraduate year 2 infectious diseases pharmacy residency programs. Am J Health-syst Pharm. 2022. Epub ahead of print.
  • Cheung NC, Noviasky JA, Ulen KR, Brangman SA. Efficacy and safety of megestrol in the hospitalized older person. Sr Care Pharm. 2022: 1;37(7):284-292
  • Lu H, Feldman EA, Seabury RW, Probst LA, Darko W, Miller CD. A single center analysis of sugammadex and neostigmine/glycopyrrolate utilization for post-operative neuromuscular blockade reversal. Trends in Anesthesia and Critical Care. 2022. https://doi.org/10.1016/ j.tacc.2022.07.001
  • Yuksel JM, Brenner JM, Britton S, Bhatti H, Noviasky JA. Optimal Injectable Haloperidol Dose Assessment in the Older Hospitalized Inpatient. Ann Pharmacother. 2023 Jun;57(6):662-668. doi: 10.1177/10600280221124615. Epub 2022 Sep 13. PMID: 36113417.
  • Yuksel JM, Noviasky JA, Britton S. Aducanumab for Alzheimer’s Disease: Summarized data from EMERGE, ENGAGE, and PRIME studies. Sr Care Pharm. 2022. 37(8):329-334.
  • Farzadeh S, Noviasky JA, Brangman SA, Yuksel JM. Impact of a clinical pharmacist telehealth service in a geriatrics assessment clinic. Sr Care Pharm. 2022. 37(7);293-303.
  • Triesel K, Seabury RW, Miller CD, Field A, Burgdorf A. Rituximab-pvvr is not an independent predictor for infusion reactions in a cohort given rituxmab-pvvr or rituximab: A single-center retrospective study. Journal of Oncology Pharmacy Practice. 2022. (Epub ahead of print)
  • Parsels KA, Seabury RW, Zyck S, Miller CD, Krishnamurthy S, Darko W, Probst LA, Latorre JG, Cwikla GM, Feldman EA. Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single center, retrospective, matched cohort analysis. American Journal of Emergency Medicine. 2022. (55):16-19.
  • Harris JL, DelVecchio D, Seabury RW, Miller CD, Phillips E. Pharmacists Act on Care Transitions in Stroke (PACT-Stroke): A Systems Approach. Clinical Therapeutics. 2022. Epub ahead of print).
  • Parels KA, Kufel WD, Burgess J, Seabury RW, Mahapatra R, Miller CD, Steele JM. Hospital discharge: An opportune time for antimicrobial stewardship. Ann Pharmacother. 2022. 56(8):869-877.

2021

  • Blow C, Harris JL, Murphy M, Conn K, Toomey C, Huml E, Phillips E. Evaluation of a Pharmacist – Led antibiotics stewardship program and implementation of prescribing order set. Journal of American Pharmacist Association 2021 online 26 Feb. https://doi.org/10.1016/j.japh.2021.01.030
  • Darko W, Seabury RW, Miller CD, Spinler SA, Probst LA, Cleary LM, Kelly CE, Kufel WD. Implementation of a Formal Pharmacy Residency Research Certificate Program. 2021 AJHP; 78(5):436–446, https://doi.org/10.1093/ajhp/zxaa424
  • Arieno J, Seabury RW, Kufel WD, Darko W, Miller CD, Paolo W, Cwikla GM, Riddell S, and Steele JM. Validation of MRSA Risk factors in Predicting MRSA Community7 Acquired Pneumonia at an Academic Medical Center. Hospital Pharmacy 2021: Hospital Pharmacy 2021. https://doi.org/10.1177/00185787211010149
  • Agedal KJ, Feldman EA, Seabury RW, Darko W, Probst LA, Miller CD, Cwikla GM. Prophylactic Enoxaparin in Critically Ill Trauma Patients: Evaluation of the Initial Dose. Hospital Pharmacy Dec 2021 DOI: 10.1177/00185787211067374
  • Kelly CE, Miller CD, Darko W, Cwikla GM, Mogle BT, Featherly J, Marcinak R, Probst LA, Seabury RW. A single-center cost analysis assessing a change in vasopressin formulation. AJHP. 2021. (Epub ahead of print).
  • Kelly CE, Miller CD, Darko W, Cwikla GM, Mogle BT, Featherly J, Marcinak R, Probst LA, Seabury RW. A Single-Center Cost-Analysis Assessing a Change in Vasopressin Formulation. AJHP 2021;78(13):11238-1243 https://doi.org/10.1093/ajhp/zxab153
  • Kufel WD, Asiago-Reddy EA, Parsels KA, Sanyal S, Coyne JL. Successful treatment with secnidazole for trichomoniasis in the setting of metronidazole hypersensitivity. Int J STD AIDS. 2021. 32(13):1271-1273.
  • Kufel WD, Mastro KA, Steele JM, Wang D, Riddell SW, Paolino KM, Thomas SJ. Impact of a pharmacist-facilitated, evidenced-based bundle initiative on Staphylococcus aureus bacteremia management. 2021. 101(4). Epub ahead of print.
  • Parsels KA, Seabury RW, Darko W, Probst LA, Steele JM. Recurrent Renal Dysfunction Secondary to Probable Piperacillin-Tazobactam-Induced Acute Interstitial Nephritis. Annals of Pharmacotherapy 2021; 55(1): 133.
  • Parels KA, Kufel W, Burgess W, Seabury RW, Mahapatra DO, Miller CD, Steele JM. Hospital Discharge: An Opportune Time for Antimicrobial Stewardship. Annals of Pharmacotherapy. 2021. (Epub ahead of print).
  • Parsels KA, Mastro KA, Steele JM, Thomas SJ, Kufel WD. Cefiderocol: a novel siderophone cephalosporin for multidrug-resistant Gram-negative bacterial infections. J Antimicrob Chemother. 2021. 12;76(6):1379-1391.
  • Parsels KA, Mastro K, Steele JM, Thomas S, and Kufel WD. A Novel Siderophore Cephalosporin for Multidrug Resistant Gram-Negative Bacterial Infections. Journal of Antimicrobial Chemotherapy.2021 Feb Published online ahead of print. PMID: 33532823DOI: 10.1093/jac/dkab015
  • Shtoyko AN, Cwikla GM, Feldman EA, Darko W, Miller CD, Seabury RW. Trust your gut: Effect of a pharmacist-driven pilot project to decrease alvimopan use past gastrointestinal recovery in post-surgical patients. AJHP 2021 Dec;78: S101-S104 https://doi.org/10.1093/ajhp/zxab331
  • Shtoyko AN, Cwikla GM, Feldman EA, Darko W, Green R, Seabury RW. Use of an argatroban systemic infusion and purge solution in a patient with a percutaneous ventricular assist device with suspected HIT. AJHP 2021 Aug 1;79(1): e8-e13 https://doi.org/10.1093/ajhp/zxab331

2020

  • Beccari MV, Seabury RW, Mogle BT, Kufel WD, Miller CD, Steele MJ. Cost comparison of AUC:MICe versus trough-based vancomycin monitoring for MRSA bacteremia. J of American Pharm Asso 2020 doi.org/10.1016/j.japh.2020.02.025.
  • Parsels KA, Seabury RW, Darko W, Probst AL, Cwikla, MG, Miller CD. Is it truly ‘alpha’? Incidence of thrombotic events with andexanet alfa at a single academic medical center. Annals of Emergency medicine. 2020;75(5): 675-676 https://doi.org/10.1016/j.annemergmed.2019.12.026
  • Shakeraneh P, Robinson R, Kufel WD, Tumey N, Benjamin SR,  Miller CD,  Darko W,  Probst LA, Seabury RW. Chemical and Physical Stability of an Admixture Containing Cefepime and Vancomycin in Lactated Ringer Solution. Hospital Pharmacy 2020. doi: 1177/0018578719901278.
  • Shakeraneh P, Fazili T, Wang D,  Steele JM, Seabury RW,  Miller CD,  Darko W,  Probst LA, Kufel WD. Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program. Pharmacotherapy 2020: doi:10.1002/phar.2381.
  • Scrimenti A, Probst LA, Miller CD, Ulen K, Noviasky JA, Seabury RW. Verifying Medication Orders in the Older Populations: Are we using Enough Caution? Sr Care Pharm2020;34:182 – 6.

 2019

  • Beccari MV, Mogle BT, Sidman EF, Mastro KA, Asiago-Reddy E, Kufel WD. Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. Antimicrobial Agents and Chemotherapy. 2019;63(6). doi:10.1128/aac.00110-19.
  • Beitz ER, Seabury RW, Miller CD, Darko W, Probst LA, Steidl KE. Clonidine for Dexmedetomidine Withdrawal in Pediatric Patients: A Single Center's Experience. The Journal of Pediatric Pharmacology and Therapeutics: 2019, Vol. 24, No. 6, pp. 542-543.
  • Blow CA, Probst LA, Miller CD, Seabury RW. Andexanet Alfa: Preferred Treatment or Therapeutic Option?.P T. 2019;44(9):533.
  • Darko W, Fancher JL, Feldman EA, Krasniak AE, Miller CD, Probst LA. Evaluating the design and conduct of teaching, education, and dissemination of knowledge learning experiences: A survey of American Society of Health System Pharmacists (ASHP)-accredited postgraduate year 1 pharmacy residency programs (TEDKLE-PGY1 survey).Journal of the American College of Clinical Pharmacy. 2019;2(5):544-553. doi:10.1002/jac5.1117.
  • Feldman EA, Noviasky JA, Ulen KR, Miller CD, Barbagallo D, Seabury RW. Targeted Medication Deprescribing in the Elderly: Results of a Pharmacist-Driven Procedure in a Transitional Care Unit. Sr Care Pharm 2019;34:678 – 684.
  • Feldman EA, Meola G, Zyck S, et al. Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients with Antiplatelet-Associated Intracranial Hemorrhage. Critical Care Medicine. 2019:1. doi:10.1097/ccm.0000000000004021.
  • Fovel LM, Miller CD, Seabury RW, Probst LA, Horvath L. Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy. P T. 2019 Jun;44(6):364.
  • Fovel LM, Robert SW, Miller CD, Darko W, Probst LA, Horvath L. Safety and Efficacy of Direct Oral Anticoagulant Therapy in Patients with Cancer. Journal of Pharmacy Practice Dec 2019 online publication. doi: 10.1177/0897190019896500.
  • Krasniak A, Szymaniak G, Conn KM, Phillips E. Evaluation of clinical pharmacy priority scoring methods in an adult medicine residency clinic. Journal of the American College of Clinical Pharmacy. 2019. doi:10.1002/jac5.1110.
  • Kufel WD, Seabury RW, Mogle BT, Beccari MV, Probst LA, Steele JM. Readiness to implement vancomycin monitoring based on area under the concentration–time curve: A cross-sectional survey of a national health consortium. American Journal of Health-System Pharmacy. 2019;76(12):889-894. doi:10.1093/ajhp/zxz070.
  • Kufel WD, Eranki AP, Paolino KM, Call A, Miller CD, Mogle BT. In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis. Journal of Antimicrobial Chemotherapy. 2019;74(7):2117-2118. doi:10.1093/jac/dkz103.
  • Lorenzo MP, Burgess J, Darko W. Intravenous Olanzapine in a Critically Ill Patient: An Evolving Route of Administration. Hospital Pharmacy. January 2019. doi:10.1177/0018578718823484.
  • Mogle BT, Beccari MV, Steele JM, Fazili T, Kufel WD. Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections. Expert Opinion on Pharmacotherapy. 2019;20(8):903-907. doi:10.1080/14656566.2019.1594774.
  • Mogle BT, Baccari MV, Fazili T, Steele JM, Kufel WD. Oral antibiotics for Eneterobacteriacae bacteremia: Should betalactams be part of the conversation: Expert Opin Pharmacother 2019; Epub ahead of print.
  • Scrimenti A, Seabury RW, Miller CD, et al. Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit. Pharmacy Practice. 2019;17(4):1541 - 1546. doi:10.18549/pharmpract.2019.4.1541.
  • Seabury RW, Darko W, Miller CD, Steele JM, Kufel WD. Publications for Pharmacy Residents Are Challenging but Not “Nearly Unattainable Hospital Pharmacy 2019: 55(3);154 doi: 1177/0018578719882316.
  • White TR, Seabury RW, Darko W, Probst LA, Miller CD. Two High to Start? Targeting a New Starting Dose for Argatroban Infusions. Journal of Pharmacy Technology. May 2019 :875512251987269. doi:10.1177/8755122519872698.
  • Zuern A, Probst LA, Darko W, et al. Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated with Intravenous Regular Insulin. Hospital Pharmacy. April 2019. doi:10.1177/0018578719841035.

2018

  • Fancher JL, Seabury RW, Darko W, Probst LA, Miller CD. Evaluation of a Long-Acting Opioid Restriction Policy: Does Restriction Reduce the Need for Naloxone Reversal? Hospital Pharmacy. May 2018. doi:10.1177/0018578718817471.
  • Fancher J, Meola G, Paolo W, Seabury RW. Retrospective assessment of succinylcholine use in acute stroke care: What are the risks? The American Journal of Emergency Medicine. 2018;36(11):2119-2120. doi:10.1016/j.ajem.2018.03.047.
  • Feldman EA, Miller CD, Wojnowicz S, Seabury RW. Significant Hyperbilirubinemia and Acute Hepatocellular Jaundice in a Pediatric Patient Receiving Deferasirox: A Case Report. The Journal of Pediatric Pharmacology and Therapeutics. 2018;23(1):64-67. doi:10.5863/1551-6776-23.1.64.
  • Kufel WD, Eranki AP, Paolino KM, Call A, Miller CD, Mogle BT. In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis. Journal of Antimicrobial Chemotherapy. 2019;74(7):2117-2118. doi:10.1093/jac/dkz103.
  • Mogle BT, Steele JM, Seabury RW, Dang UJ, Kufel WD. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. International Journal of Antimicrobial Agents. 2018;52(6):805-810. doi:10.1016/j.ijantimicag.2018.08.024.
  • Mogle BT, Seabury RW, Jones Z, Miller CD, Steele JM. The Culture of Carbapenem Overconsumption: Where Does It Begin? Results of a Single-Center Survey. Hospital Pharmacy. 2018;54(3):175-179. doi:10.1177/0018578718775328.
  • Mogle BT, Steele JM, Thomas SJ, Bohen KH, Kufel WD. Clinical Review of Delafloxacin: A Novel Anionic fluoroquinolone. J Amtiomicrob Chemother. 2018;73(6):1439 – 1451.
  • Rose P, Cwikla G, Miller CD, Probst LA, Seabury RW. Price-Performance Ratio Analysis of Enteral Vitamin K Formulations. P T. 2018 Mar;43(3):168-170.
  • Stoessel AM, Hale CM, Seabury RW, Miller CD, Steele JM. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant Staphylococcus aureus infection. Journal of Pharmacy Practice. 2018;32(4):442-446. doi:10.1177/0897190018764564.

2017

  • Feldman EA, Miller CD, Wojnowicz S, Seabury RW. Significant hyperbilirubinemia and acute hepatocellular jaundice in a pediatric patient receiving deferasirox: a case report. J Pediatr Pharmacol Ther. 2017. [Epub ahead of print].
  • Gill D, Feldman EA, Liu K. Evaluation of medication compliance for secondary prevention of acute coronary syndrome. Proc (Bayl Univ Med Cent). 2017. [Epub ahead of print].
  • Gill D, Schrader J, Kelly M, Martinez F, Syed W, Wright. Gemcitabine associated pseudocellulitis: A missed diagnosis. J Oncol Pharm Pract. 2017. [Epub ahead of print].
  • Hale CM, Steele JM, Seabury RW, Miller CD. Characterization of drug-related problems occurring in patients receiving outpatient antimicrobial therapy. J of Pharm Practice. 2017. [Epub ahead of print].
  • Krasniak A, Darko W, Miller CD, Seabury RW, Probst LA. Changes in pharmacy residency training design between 2012 and 2017: A perspective of academic medical centers. Hosp Pharm. 2017. [Epub ahead of print].
  • Kufel WD, Miller CD, Johnson PR, Reid K, Zahra JJ, Seabury RW. Y-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: Do current compatibility testing methodologies tell the whole story? Hosp Pharm. 2017; 52(2): 132-137.
  • Kufel WD, Seabury RW, Darko W, Probst LA, Miller CD. Clinical feasibility of monitoring enoxaparin anti-Xa concentrations: Are we getting it right? Hosp Pharm. 2017;52(3):214-220.
  • Kufel WD, Seabury RW, Meola GM, Darko W, Probst LA, Miller CD. Impact of premix antimicrobial preparation and time to administration in septic patients. CJEM. 2017. [Epub ahead of print].
  • Lorenzo MP, MacConaghy L, Miller CD, Meola G, Probst LA, Pratt B, Steele J, Seabury RW. Impact of a combination antibiotic bag on compliance with surviving sepsis campaign goals in emergency department patients with severe sepsis and septic shock. Ann Pharmacother. 2017. [Epub ahead of print].
  • Mogle BT, Seabury RW, Jennings S, Cwikla GM. Severe neutrophilic dermatosis following submental deoxycholic acid administration. Clin Toxicol. 2017. [Epub ahead of print].
  • Probst LA, Welch TR. Pediatric drug formulations – unintended consequences of legislation. N Engl J Med. 2017; 376: 795-796.
  • Rose P, Seabury RW, Cwikla G. Acutre hepatocellular jaundice after dofetilide initiation: A case report. Hosp Pharm. 2017. [Epub ahead of print].
  • Seabury RW, Stoessel AM, Steel JM. Vancomycin trough concentration poorly characterizes AUC: Is it time to transition to AUC-based vancomycin monitoring? Annals of Pharmacotherapy. June, 2017. [Epub ahead of print].
  • Steele JM, Seabury RW, Hale CM, Mogle BT. Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin. J Clin Pharm Ther. 2017. [Epub ahead of print].

 2016

  • Hale CM, Seabury RW, Steele JM, Darko W, Miller CD. Are Vancomycin Trough Concentrations of 15-20 mg/dL Associated with Increased Attainment of an AUC/MIC ≥ 400 in Patients with Presumed MRSA Injection? Journal of Pharmacy Practice. 2016. [Epub ahead of print].
  • Kufel WD, Hale CM, Sideman EF, Orellana CE, Miller CD. Nucleoside Reverse Transcriptase Inhibitor (NRTI) Associated Macrocytosis. International Journal of Virology and AIDS. 2016; 3(18).
  • Kufel WD, Scrimenti A, Steele JM. A case of septic shock due to Serratia marcescens pyelonephritis and bacteremia in a patient receiving empagliflozin. J Pharm Pract. 2016. [Epub ahead of print].
  • Kufel WD, Zayac AS, Lehmann DF, Miller CD. Clinical application and pharmacodynamic monitoring in a patient with end-stage renal disease requiring chronic hemodialysis. Pharmacotherapy. 2016. 35(11):e166-e171
  • Phillips E, Saseen JJ. Current controversies with recent cholesterol treatment guidelines. J Pharm Pract. 2016. 29(1):15-25.
  • Sigona NS, Steele JM, Miller CD. Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: A pilot project. Journal of the American Pharmacist Association. 2016. [Epub ahead of print].
  • Stambough M, Roman M, Blair DC, Sidman EF, Miller CD. Preemptive antiretroviral therapy modifications for the management of potentially clinically significant drug interactions with direct acting hepatitis C therapies. Int J STD AIDS. 2016; 27(3):235-7.
  • Wills B, Darko W, Seabury RW, Probst LA, Miller CD, Cwikla GM. Pharmacy impact on medication reconciliation in the medical intensive care unit. J of Research in Pharmacy Practice. 2016;5(2):142-5.

2015

  • Noviasky JA, Darko W, Akajabor D, Makaron A, Miller CD, Pierce D, Seabury RW, Whalen K. Digoxin (Textbook Chapter). Casebook in Clinical Pharmacokinetics, 1st Edition. Henry Cohen, editor, McGraw Hill; 2015

2014

  • Francois D, Roberts J, Hess S, Probst LA, Eksioglu Y. Medical management with diazepam for electrical status epilepticus during slow wave sleep in children. Pediatr Neurol. 2014;50(3):238-42.
  • Noviasky JA, Pierce DP, Whalen K, Guharoy R, Hildreth K. Bupivacaine Liposomal Versus Bupivacaine: Comparative Review. (Response) Hosp Pharm 2014;49(9);793-795.
  • Noviasky JA, Pierce DP, Whalen K, Guharoy R, Hildreth K. Bupivacaine Liposomal Versus Bupivacaine: Comparative Review. Hosp Pharm 2014;49(6):539-543.
  • Patel N, Nasiri M, Koroglu A, Amin R, McGuey L, McNutt LA, Roman M, Miller CD. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection. AIDS Res Hum Retroviruses. 2014; 372(6): 528-36.
  • Sidman E, Probst LA, Darko W, Miller CD. Evaluation of Dabigatran Utilization and Risk Among Hospitalized Patients. Ann Pharmacother. 2014; 48(3):349-53.

2013

  • Guharoy R, Noviasky JA, Haydar Z, Fakih MG, Hartman C. Compounding Pharmacy Conundrum: "We cannot live without them, but we cannot live with them" according to the present paradigm. Chest 2013 Apr;143:896-900

2012

  • Noviasky JA, Kelberman M. Nesiritide. Were the signals missed amid the marketing? Cardiology Today July 2012
  • Shaifali S, Karachiwala H, Noviasky J, Wong D, Elliott WC, Lehmann D. To bind or to let loose: Effectiveness of sodium polystyrene sulfonate in decreasing serum potassium. 2012 Inter J Nephrology Article ID 940320
  • Suryadevara M, Steidl KE, Probst LA, Shaw J. Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs. J Pediatr Pharmacol Ther. 2012; 17(2):159-65.

2010

  • Burchett DK, Darko W, Zahra J, Noviasky JA, Probst LA, Smith A. Mixing and compatibility guide for commonly used aerosolized medications. Am J Health Syst Pharm. 2010;67(3):227-30.
  • Steidl KE, Darko W. Probst LA, Noviasky JA, Nasser S. Rhabdomyolysis associated with phentermine. Am J Health Syst Pharm. 2010;67(22):1929-32.
Top